We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.

placeholder="Enter search term...">
Suitcase

Vaccine Supply Update

21 December 2017

The following is an update provided by Public Health England on the supply situation for vaccines purchased direct from the manufacturers (e.g. for travel and risk groups):

Diphtheria, Tetanus and Poliomyelitis (inactivated) Vaccine

  • Sanofi Pasteur: Limited supplies of Revaxis are available. There are likely to be order restrictions in place for travellers. Please contact Sanofi Pasteur for information regarding availability. Sanofi Pasteur Tel: 0148 350 5515.

Hepatitis B

To ensure vaccine availability for those at highest and most immediate risk of exposure to hepatitis B, all hepatitis B containing monovalent and bivalent (HepA/HepB) vaccines are currently under supply management processes, detailed guidance is available here

In Scotland a  mechanism is in place to allow for exceptional orders if there is an urgent and immediate need for an individual following a thorough risk assessment, this is through the local NHS Board Vaccine Holding Centrehttp://www.travax.nhs.uk/media/1200311/icon_newwindow.gif                        

Hep B Adult:

  • GSK: Limited supplies of Engerix B PFS singles are available.
  • GSK: Engerix B PFS packs of 10 are currently available.
  • GSK: Very limited supplies of Engerix B vials are available.
  • GSK: Limited supplies of Fendrix are available.
  • MSD: Limited supplies of HBVAXPRO 10μg are available. Supplies are expected to be restricted throughout 2018.
  • MSD: Limited supplies of HBVAXPRO 40μg are available. Supplies are expected to be restricted throughout 2018.

Hep B Paediatric:

  • GSK: limited supplies of Engerix B Paediatric singles are available.
  • MSD: Limited supplies of HBVAXPRO 5μg are available. Supplies are expected to be restricted throughout 2018.

Hepatitis A Vaccine

Hep A Adult:

  • GSK: Havrix PFS singles and Havrix PFS packs of 10 are currently unavailable and are unlikely to be available until 2018.
  • Sanofi Pasteur: Limited supplies of Avaxim are available. It is likely that there will be order restrictions in place.
  • MSD: There will be restricted supplies of VAQTA for the remainder of 2017.

Hepatitis A Paediatric:

  • GSK: Havrix Paediatric singles and packs of 10 will experience supply constraints for the remainder of 2017.
  • MSD: Limited supplies of VAQTA Paediatric are available.

Combined Hepatitis A and Hepatitis B Vaccine

  • GSK: Limited supplies of Twinrix Adult and Paediatric presentations are available for high risk travellers and other patients requiring both Hepatitis A & B components.
  • GSK: Limited supplies of Ambirix is available for high risk travellers and other patients requiring both Hepatitis A & B components.

Combined Hepatitis A and Typhoid

  • GSK is discontinuing Hepatyrix vaccine.
  • Sanofi Pasteur: Limited supplies of Viatim are available. It is likely there will be order restrictions in place.

Typhoid

  • GSK is discontinuing Typherix.
  • Sanofi Pasteur: Limited supplies of Typhim are available. It is likely there will be order restrictions in place. The restrictions are likely to improve in January 2018.
  • PaxVax: Vivotif is available.

Rabies

  • GSK: Limited supplies of Rabipur are available.
  • Sanofi Pasteur: licensed Rabies Vaccine BP is currently unavailable for daily sales. For more information contact Sanofi Pasteur.

Contact Details:

  • GSK Tel: 0208 047 5000
  • Sanofi Pasteur Tel: 0148 350 5515
  • MSD Tel: 0199 245 2094
  • PaxVax Tel: 0152 521 7516